Form 4 for BMEA Biomea Fusion, Inc.
Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-01 · accession 0000899243-22-021082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-06-03 | 2022-06-01 | BMEA | Biomea Health, LLC | 10% | J - Other | $0.00 | -4.37M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-01 | J | D | 4,365,342 | $0.00 | 0 | I See Footnote | — | — | (F1) On June 1, 2022, Biomea Health, LLC distributed in-kind, without consideration, in the aggregate 4,365,342 shares of the Issuer's Common Stock pro-rata to its members, in accordance with the exemption under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended. No shares were sold by the members. (F2) These shares are held directly by Biomea Health, LLC. Rainer M. Erdtmann and Thomas Butler are members of the Issuer's Board of Directors and members of the Reporting Person. |